Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 38, Issue 2, 2001, Pages 322-330

  Erdmann, Jeanette ^a   Raible, Jörg ^a   Maki Abadi, Jaleh ^a   Hummel, Manfred ^a   Hammann, Jan ^a   Wollnik, Bernd ^b   Frantz, Eckart ^a   Fleck, Eckart ^a   Hetzer, Roland ^a   Regitz Zagrosek, Vera ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN BINDING PROTEIN C;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PATHOGENESIS; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; COHORT STUDIES; FAMILY HEALTH; FEMALE; FOUNDER EFFECT; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; VARIATION (GENETICS);

EID: 0034907103     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01387-0     Document Type: Article

References (30)

1. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease
2. Novel insights into the clinical manifestations and treatment of hypertrophic cardiomyopathy
3. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
4. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene
5. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
6. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
7. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy
8. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
9. A molecular basis for familial hypertrophic cardiomyopathy: A beta-cardiac myosin heavy chain gene missense mutation
10. An on-line locus-specific mutation database for familial hypertrophic cardiomyopathy
11. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
12. Prognostic implications of novel beta-cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy
13. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy
14. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene
15. Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy
16. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
17. Prevalence of hypertrophic cardiomyopathy in a general population of young adults
18. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia
19. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction?
20. A molecular map of the interactions between titin and myosin-binding protein C: Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy
21. Identification of the A-band localization domain of myosin binding proteins C and H (MyBP-C, MyBP-H) in skeletal muscle
22. Human myosin-binding protein H (MyBP-H): Complete primary sequence, genomic organization, and chromosomal localization
23. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
24. Assembly of cardiac C-protein during myofibrillogenesis in myogenic cells in culture
25. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
26. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy
27. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy: Characterization of cardiac transcript and protein
28. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance
29. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis
30. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events